Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thromb Haemost. 2018 Aug; 118(8):1439-1449.
View in:
PubMed
subject areas
Aged
Aged
Anticoagulants
Anticoagulants
Clinical Decision-Making
Clinical Decision-Making
Dalteparin
Dalteparin
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Neoplasms
Neoplasms
Patient Selection
Patient Selection
Pyridines
Pyridines
Recurrence
Recurrence
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Severity of Illness Index
Severity of Illness Index
Thiazoles
Thiazoles
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
authors with profiles
Gary E Raskob